vs
Side-by-side financial comparison of Enhabit, Inc. (EHAB) and UNIVERSAL TECHNICAL INSTITUTE INC (UTI). Click either name above to swap in a different company.
Enhabit, Inc. is the larger business by last-quarter revenue ($270.4M vs $220.8M, roughly 1.2× UNIVERSAL TECHNICAL INSTITUTE INC). UNIVERSAL TECHNICAL INSTITUTE INC runs the higher net margin — 5.8% vs -14.3%, a 20.1% gap on every dollar of revenue. On growth, UNIVERSAL TECHNICAL INSTITUTE INC posted the faster year-over-year revenue change (9.6% vs 4.7%). Enhabit, Inc. produced more free cash flow last quarter ($3.3M vs $-19.2M). Over the past eight quarters, UNIVERSAL TECHNICAL INSTITUTE INC's revenue compounded faster (9.5% CAGR vs 1.5%).
Enhabit, Inc., is a Dallas, Texas-based provider of home health and hospice services. The company operates 255 home health and 110 hospice locations in 34 states with a concentration in Texas, Alabama, Florida, Georgia, Oklahoma and Mississippi. Enhabit is the fourth-largest provider of home health services in the United States and is a leading provider of hospice services. The company was formed in 2022 when Encompass Health spun off its home health and hospice business.
Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.
EHAB vs UTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $270.4M | $220.8M |
| Net Profit | $-38.7M | $12.8M |
| Gross Margin | — | — |
| Operating Margin | -12.3% | 7.1% |
| Net Margin | -14.3% | 5.8% |
| Revenue YoY | 4.7% | 9.6% |
| Net Profit YoY | 15.9% | -42.1% |
| EPS (diluted) | $-0.76 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.4M | $220.8M | ||
| Q3 25 | $263.6M | $222.4M | ||
| Q2 25 | $266.1M | $204.3M | ||
| Q1 25 | $259.9M | $207.4M | ||
| Q4 24 | $258.2M | $201.4M | ||
| Q3 24 | $253.6M | $196.4M | ||
| Q2 24 | $260.6M | $177.5M | ||
| Q1 24 | $262.4M | $184.2M |
| Q4 25 | $-38.7M | $12.8M | ||
| Q3 25 | $11.1M | $18.8M | ||
| Q2 25 | $5.2M | $10.7M | ||
| Q1 25 | $17.8M | $11.4M | ||
| Q4 24 | $-46.0M | $22.2M | ||
| Q3 24 | $-110.2M | $18.8M | ||
| Q2 24 | $-200.0K | $5.0M | ||
| Q1 24 | $200.0K | $7.8M |
| Q4 25 | -12.3% | 7.1% | ||
| Q3 25 | 6.4% | 11.2% | ||
| Q2 25 | 6.3% | 6.9% | ||
| Q1 25 | 6.1% | 8.1% | ||
| Q4 24 | -16.0% | 13.6% | ||
| Q3 24 | -38.6% | 13.3% | ||
| Q2 24 | 4.3% | 4.2% | ||
| Q1 24 | 4.9% | 6.1% |
| Q4 25 | -14.3% | 5.8% | ||
| Q3 25 | 4.2% | 8.4% | ||
| Q2 25 | 2.0% | 5.2% | ||
| Q1 25 | 6.8% | 5.5% | ||
| Q4 24 | -17.8% | 11.0% | ||
| Q3 24 | -43.5% | 9.6% | ||
| Q2 24 | -0.1% | 2.8% | ||
| Q1 24 | 0.1% | 4.2% |
| Q4 25 | $-0.76 | $0.23 | ||
| Q3 25 | $0.22 | $0.33 | ||
| Q2 25 | $0.10 | $0.19 | ||
| Q1 25 | $0.35 | $0.21 | ||
| Q4 24 | $-0.92 | $0.40 | ||
| Q3 24 | $-2.20 | $0.35 | ||
| Q2 24 | $0.00 | $0.09 | ||
| Q1 24 | $0.01 | $0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $43.6M | $162.8M |
| Total DebtLower is stronger | $426.0M | $101.4M |
| Stockholders' EquityBook value | $534.0M | $335.9M |
| Total Assets | $1.2B | $834.0M |
| Debt / EquityLower = less leverage | 0.80× | 0.30× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $43.6M | $162.8M | ||
| Q3 25 | $56.9M | $169.1M | ||
| Q2 25 | $37.1M | $70.7M | ||
| Q1 25 | $39.5M | $96.0M | ||
| Q4 24 | $28.4M | $172.0M | ||
| Q3 24 | $45.7M | $161.9M | ||
| Q2 24 | $28.5M | $115.5M | ||
| Q1 24 | $36.5M | $116.1M |
| Q4 25 | $426.0M | $101.4M | ||
| Q3 25 | $441.5M | $87.1M | ||
| Q2 25 | $456.9M | $73.8M | ||
| Q1 25 | $467.3M | $94.4M | ||
| Q4 24 | $492.6M | $120.1M | ||
| Q3 24 | $502.9M | $125.7M | ||
| Q2 24 | $512.7M | $137.3M | ||
| Q1 24 | $526.7M | $141.9M |
| Q4 25 | $534.0M | $335.9M | ||
| Q3 25 | $566.8M | $328.1M | ||
| Q2 25 | $552.4M | $306.8M | ||
| Q1 25 | $543.2M | $293.9M | ||
| Q4 24 | $523.5M | $280.0M | ||
| Q3 24 | $566.1M | $260.2M | ||
| Q2 24 | $674.3M | $239.4M | ||
| Q1 24 | $672.3M | $232.6M |
| Q4 25 | $1.2B | $834.0M | ||
| Q3 25 | $1.2B | $826.1M | ||
| Q2 25 | $1.2B | $740.8M | ||
| Q1 25 | $1.2B | $720.4M | ||
| Q4 24 | $1.2B | $753.8M | ||
| Q3 24 | $1.3B | $744.6M | ||
| Q2 24 | $1.4B | $706.0M | ||
| Q1 24 | $1.4B | $702.1M |
| Q4 25 | 0.80× | 0.30× | ||
| Q3 25 | 0.78× | 0.27× | ||
| Q2 25 | 0.83× | 0.24× | ||
| Q1 25 | 0.86× | 0.32× | ||
| Q4 24 | 0.94× | 0.43× | ||
| Q3 24 | 0.89× | 0.48× | ||
| Q2 24 | 0.76× | 0.57× | ||
| Q1 24 | 0.78× | 0.61× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.4M | $3.1M |
| Free Cash FlowOCF − Capex | $3.3M | $-19.2M |
| FCF MarginFCF / Revenue | 1.2% | -8.7% |
| Capex IntensityCapex / Revenue | 0.4% | 10.1% |
| Cash ConversionOCF / Net Profit | — | 0.24× |
| TTM Free Cash FlowTrailing 4 quarters | $65.8M | $16.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.4M | $3.1M | ||
| Q3 25 | $37.8M | $57.1M | ||
| Q2 25 | $10.6M | $18.1M | ||
| Q1 25 | $17.9M | $-789.0K | ||
| Q4 24 | $-4.1M | $23.0M | ||
| Q3 24 | $28.4M | $67.5M | ||
| Q2 24 | $9.6M | $10.0M | ||
| Q1 24 | $17.3M | $-2.5M |
| Q4 25 | $3.3M | $-19.2M | ||
| Q3 25 | $36.2M | $40.6M | ||
| Q2 25 | $8.7M | $6.8M | ||
| Q1 25 | $17.6M | $-11.7M | ||
| Q4 24 | $-4.7M | $19.6M | ||
| Q3 24 | $27.7M | $60.0M | ||
| Q2 24 | $8.9M | $3.0M | ||
| Q1 24 | $15.5M | $-8.4M |
| Q4 25 | 1.2% | -8.7% | ||
| Q3 25 | 13.7% | 18.3% | ||
| Q2 25 | 3.3% | 3.4% | ||
| Q1 25 | 6.8% | -5.7% | ||
| Q4 24 | -1.8% | 9.7% | ||
| Q3 24 | 10.9% | 30.6% | ||
| Q2 24 | 3.4% | 1.7% | ||
| Q1 24 | 5.9% | -4.6% |
| Q4 25 | 0.4% | 10.1% | ||
| Q3 25 | 0.6% | 7.4% | ||
| Q2 25 | 0.7% | 5.5% | ||
| Q1 25 | 0.1% | 5.3% | ||
| Q4 24 | 0.2% | 1.7% | ||
| Q3 24 | 0.3% | 3.8% | ||
| Q2 24 | 0.3% | 4.0% | ||
| Q1 24 | 0.7% | 3.2% |
| Q4 25 | — | 0.24× | ||
| Q3 25 | 3.41× | 3.04× | ||
| Q2 25 | 2.04× | 1.69× | ||
| Q1 25 | 1.01× | -0.07× | ||
| Q4 24 | — | 1.04× | ||
| Q3 24 | — | 3.58× | ||
| Q2 24 | — | 2.01× | ||
| Q1 24 | 86.50× | -0.32× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EHAB
| Third Party Payor Medicare | $111.6M | 41% |
| Third Party Payor Medicare Advantage | $67.5M | 25% |
| Hospice Segment | $63.6M | 24% |
| Third Party Payor Managed Care | $24.9M | 9% |
| Third Party Payor Medicaid | $1.7M | 1% |
UTI
| UTI | $142.8M | 65% |
| Concorde | $78.0M | 35% |
